Hyperthyroid monkeys: A nonhuman primate model of experimental Graves' disease

Journal of Endocrinology

Volumn 219, Issue 3, 2013, Pages 183-193

  Wang, Y ^a   Wu, L P ^a   Fu, J ^a   Lv, H J ^a   Guan, X Y ^a   Xu, L ^a   Chen, P ^a   Gao, C Q ^a   Hou, P ^a   Ji, M J ^a   Shi, B Y ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Graves' disease; Rhesus monkeys; Thyrotropin receptor A subunit

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; THYROTROPIN RECEPTOR; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FREE THYROXINE INDEX; GRAVES DISEASE; HAPLORHINI; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; TH1 TH2 BALANCE; THYROID HORMONE BLOOD LEVEL; TISSUE SECTION;

GRAVES' DISEASE; RHESUS MONKEYS; THYROTROPIN RECEPTOR A-SUBUNIT;

ANIMALS; ANTIGENS; AUTOANTIBODIES; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; FEMALE; GENE TRANSFER TECHNIQUES; GRAVES DISEASE; HUMANS; IMMUNOTOXINS; MACACA MULATTA; ORGAN SIZE; PROTEIN SUBUNITS; RECEPTORS, THYROTROPIN; RECOMBINANT PROTEINS; TH1 CELLS; TH17 CELLS; TH2 CELLS; THYROID GLAND; THYROXINE;

EID: 84890153973     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0279     Document Type: Article

References (36)

1. Barrett K, Liakata E, Rao PV,Watson PF, Weetman AP, Lymberi P, Banga JP & Carayanniotis G 2004 Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor. Clinical and Experimental Immunology 136 413-422.
2. Chazenbalk GD 2002 Thyroid-stimulating autoantibodies in Graves' disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. Journal of Clinical Investigation 110 209-217.
3. Chen CR 2003a Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease. Endocrinology 145 228-233.
4. Chen CR 2003b The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim. Journal of Clinical Investigation 111 1897-1904.
5. Chen P, Kovesdi I & Bruder JT 2000 Effective repeat administration with adenovirus vectors to the muscle. Gene Therapy 7 587-595.
6. Disotell TR & Tosi AJ 2007 The monkey's perspective. Genome Biology 8 226.
7. Figueroa-Vega N, Alfonso-Perez M, Benedicto I, Sanchez-Madrid F, Gonzalez-Amaro R & Marazuela M 2010 Increased circulating proinflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism 95 953-962.
8. Ganesh BB, Bhattacharya P, Gopisetty A & Prabhakar BS 2011 Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. Journal of Interferon & Cytokine Research 31 721-731.
9. Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM, Mardis ER, Remington KA, Strausberg RL, Venter JC, Wilson RK et al. 2007 Evolutionary and biomedical insights from the rhesus macaque genome. Science 316 222-234.
10. Horie I, Abiru N, Saitoh O, Ichikawa T, Iwakura Y, Eguchi K & Nagayama Y 2011 Distinct role of T helper type 17 immune response for Graves' hyperthyroidism in mice with different genetic backgrounds. Autoimmunity 44 159-165.
11. Latrofa F, Chazenbalk GD, Pichurin P, Chen CR, McLachlan SM & Rapoport B 2004 Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies. Journal of Clinical Endocrinology and Metabolism 89 4734-4745.
12. Lazarus JH 2012 Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease. Best Practice & Research. Clinical Endocrinology & Metabolism 26 273-279.
13. Lichiardopol C & Mota M 2009 The thyroid and autoimmunity. Romanian Journal of Internal Medicine 47 207-215.
14. McLachlan SM, Nagayama Y & Rapoport B 2005 Insight into Graves' hyperthyroidism from animal models. Endocrine Reviews 26 800-832.
15. McLachlan SM, Alpi K & Rapoport B 2011 Review and hypothesis: does Graves' disease develop in non-human great apes? Thyroid 21 1359-1366.
16. Mizutori Y, Saitoh O, Eguchi K & Nagayama Y 2006 Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice. Journal of Autoimmunity 26 32-36.
17. Mosmann TR & Coffman RL 1989 TH1 and TH2 cells: different patterns of lymphokine secretion leadto different functional properties.AnnualReview of Immunology 7 145-173.
18. Nagayama Y 2005 Animal models of Graves' hyperthyroidism. Endocrine Journal 52 385-394.
19. Nagayama Y 2007 Graves' animal models of Graves' hyperthyroidism. Thyroid 17 981-988.
20. Nagayama Y, Mizuguchi H, Hayakawa T, Niwa M, McLachlan SM & Rapoport B 2003 Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine. Journal of Immunology 170 3522-3527.
21. Nanba T, WatanabeM, Inoue N & Iwatani Y 2009 Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid 19 495-501.
22. Pennisi E 2007 Boom time for monkey research. Science 316 216-218.
23. Pichurin PN, Chen CR, Chazenbalk GD, Aliesky H, Pham N, Rapoport B & McLachlan SM 2006 Targeted expression of the human thyrotropin receptor A-subunit to the mouse thyroid: insight into overcoming the lack of response to A-subunit adenovirus immunization. Journal of Immunology 176 668-676.
24. Pilankatta R, Chawla T, Khanna N & Swaminathan S 2010 The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines. Journal of Medical Virology 82 407-414.
25. Rahman A 2001 Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy. Molecular Therapy 3 768-778.
26. Singh VK, Mehrotra S & Agarwal SS 1999 The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunologic Research 20 147-161.
27. Smith BR, Sanders J & Furmaniak J 2007 TSH receptor antibodies. Thyroid 17 923-938.
28. Steinman L 2007 A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nature Medicine 13 139-145.
29. Wang SH, Chen GH, Fan Y, Van Antwerp M & Baker JR Jr 2009 Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4CCD25C regulatory T cells. Endocrinology 150 2000-2007.
30. Weaver CT & Hatton RD 2009 Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nature Reviews. Immunology 9 883-889.
31. Weaver CT, Harrington LE, Mangan PR, Gavrieli M & Murphy KM 2006 Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24 677-688.
32. Weetman AP, Yateman ME, Ealey PA, Black CM, Reimer CB, Williams RC Jr, Shine B & Marshall NJ 1990 Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. Journal of Clinical Investigation 86 723-727.
33. Wu LP, Shi BY, Guo LY, Xu L, Lan L, Liu J, Zhang JA & LR X 2006 Preparation of animal model for Graves' disease in female mice. Chinese Journal of Endocrinology and Metabolism 22 388-391.
34. Wu L, Xun L, Yang J, Xu L, Tian Z, Gao S, Zhang Y, Hou P & Shi B 2011 Induction of murine neonatal tolerance against Graves' disease using recombinant adenovirus expressing the TSH receptor A-subunit. Endocrinology 152 1165-1171.
35. Yan N, Yu YL, Yang J, Qin Q, Zhu YF, Wang X, Song RH & Zhang JA 2012 Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity 45 533-539.
36. Zhou J, Bi M, Fan C, Song X, Yang R, Zhao S, Li L, Li Y, Teng W & Shan Z 2012 Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism. Clinical and Experimental Medicine 12 39-46.